TABLE 2.
Normal-Organ Absorbed Doses for 89Zr-Trastuzumab
| Target organ | Mean | SD | Median | Minimum | Maximum |
| Adrenals | 0.57 | 0.08 | 0.57 | 0.47 | 0.73 |
| Brain | 0.24 | 0.05 | 0.25 | 0.16 | 0.31 |
| Breasts | 0.31 | 0.05 | 0.31 | 0.23 | 0.38 |
| Gallbladder wall | 0.64 | 0.08 | 0.65 | 0.52 | 0.78 |
| Lower large intestine wall | 0.43 | 0.10 | 0.42 | 0.32 | 0.65 |
| Small intestine | 0.40 | 0.06 | 0.42 | 0.30 | 0.47 |
| Stomach wall | 0.43 | 0.07 | 0.44 | 0.32 | 0.54 |
| Upper large intestine wall | 0.44 | 0.07 | 0.44 | 0.35 | 0.55 |
| Heart wall | 1.12 | 0.18 | 1.12 | 0.85 | 1.46 |
| Kidneys | 0.90 | 0.22 | 0.78 | 0.68 | 1.26 |
| Liver | 1.32 | 0.24 | 1.37 | 0.90 | 1.75 |
| Lungs | 0.81 | 0.18 | 0.77 | 0.58 | 1.17 |
| Muscle | 0.33 | 0.05 | 0.33 | 0.23 | 0.40 |
| Ovaries | 0.38 | 0.07 | 0.40 | 0.26 | 0.47 |
| Pancreas | 0.56 | 0.09 | 0.56 | 0.45 | 0.71 |
| Red marrow | 0.45 | 0.08 | 0.45 | 0.32 | 0.61 |
| Osteogenic cells | 0.50 | 0.11 | 0.50 | 0.32 | 0.69 |
| Skin | 0.23 | 0.04 | 0.23 | 0.16 | 0.29 |
| Spleen | 0.80 | 0.19 | 0.74 | 0.59 | 1.20 |
| Testes | 0.26 | 0.05 | 0.27 | 0.17 | 0.30 |
| Thymus | 0.46 | 0.06 | 0.47 | 0.34 | 0.55 |
| Thyroid | 0.31 | 0.05 | 0.32 | 0.21 | 0.36 |
| Urinary bladder wall | 0.33 | 0.05 | 0.34 | 0.23 | 0.38 |
| Uterus | 0.38 | 0.07 | 0.39 | 0.25 | 0.46 |
| Total body | 0.37 | 0.06 | 0.37 | 0.28 | 0.46 |
| Effective dose equivalent (mSv/MBq) | 0.60 | 0.09 | 0.60 | 0.49 | 0.76 |
| Effective dose (mSv/MBq) | 0.48 | 0.06 | 0.47 | 0.38 | 0.57 |
Units are mGy/MBq unless otherwise noted.